• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    XOMA Corporation (XOMA)

    -NasdaqGM
    4.01 Down 0.24(5.65%) 4:00PM EST
    |After Hours : 4.09 Up 0.08 (2.00%) 7:56PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.25
    Open:4.24
    Bid:4.07 x 100
    Ask:4.10 x 300
    1y Target Est:8.86
    Beta:4.43
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:4.00 - 4.29
    52wk Range:3.42 - 9.57
    Volume:12,956,712
    Avg Vol (3m):2,029,180
    Market Cap:430.65M
    P/E (ttm):N/A
    EPS (ttm):-1.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    XOMADown 5.65%430.65M
    NVSUp 0.04%228.83B
    REGNUp 0.91%43.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.48
    Quarterly EPS Est (Dec-14) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.46

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback